Skip to content

A registry of risk factors, screening and treatment results of developmental dysplasia of the hip (DDH) in children followed up to adulthood.

A Prospective, International Hip Dysplasia Registry (IHDR) with Follow-up to Skeletal Maturity : An Analysis of Risk Factors, Screening Practices and Treatment Outcomes

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/03/012461
Enrollment
1000
Registered
2018-03-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Developmental Dysplasia of Hip

Interventions

None listed

Sponsors

Alaric Aroojis
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a) patients aged 6 months to 10 years old at time of initial diagnosis b) Referred for DDH screening due to specific risk factors OR diagnosed with DDH c) Diagnosis confirmed with appropriate radiographic imaging d) Care provided by one or both natural or adoptive parents

Exclusion criteria

Exclusion criteria: a) Known or suspected neuromuscular, collagen, chromosomal, or lower extremity congenital anomalies b) Teratologic hip dislocation(syndrome-assosciated dislocations) c) Patients over 10 years of age at diagnosis d) Patients that have received prior treatment/surgery for DDH management without appropriate imaging or documentation

Design outcomes

Primary

MeasureTime frame
Patient-reported functional outcome scores, including measures of activity and quality of life. evidence of residual acetabular dysplasia and need for further corrective surgery prior to reaching skeletal maturity.Timepoint: 3 months, 6 months, 1 year, 2 year, 3 year , 5 year, 7 year, 10 year, 13 years, Skeletal maturity

Secondary

MeasureTime frame
Collecting patient-reported outcome measures in regard to functionality, satisfaction and quality of life will provide unique insight into the long-term impact of DDH, and particular treatment or management plans from early infancy the rate of treatment failures complication rates (femoral nerve palsy, avascular necrosis) and radiographic improvement of femoral head and acetabular morphologyTimepoint: 3 month, 6months, 1 year, 2 year, 3 year, 5 year, 7 year, 10 year, 13 year, Skeletal Maturity

Countries

Australia, Canada, India, United Kingdom, United States of America

Contacts

Public ContactAlaric Aroojis

Bai Jerbai Wadia Hospital for Children.

aaroojis@gmail.com09320284402

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026